全球野生動物健康市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球野生動物健康市場預計將從2025年的31.8億美元成長至2034年的80.2億美元，2026年至2034年的複合年成長率（CAGR）為10.82%。該市場正穩步擴張，這得益於人們對生物多樣性保護、通用感染疾病預防和生態系統永續性的日益重視。各國政府、自然保護機構和研究機構正增加對野生動物疾病監測、獸醫照護和棲息地保護的投入，以保護動物族群。人們對野生動物健康、環境穩定和公共衛生之間相互關係的認知不斷加深，也進一步推動了該產業的成長。

野生動物診斷、疾病監測技術、分子檢測和遠端追蹤系統的進步，正在改善野生動物族群感染疾病的檢測和管理。保育計畫擴大利用數位健康監測工具和先進的獸醫療法來提高復原效果。合作研究舉措也正在加強全球生態系統中的疾病預防策略。

前景依然光明，這主要得益於對野生動物保護、環境監測和先進獸醫學研究投入的不斷增加。人工智慧、基因組學和遙感探測技術可望協助提升疾病監測和生態系統管理水準。全球對生物多樣性保護和「同一健康」舉措的持續關注，將為該行業的長期發展創造重大機會。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：本節詳細評估影響市場成長的主要促進因素、限制因素、機會和挑戰。內容涵蓋技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球野生動物健康市場：依動物類型分類

• 市場分析、洞察與預測
• 哺乳動物
• 鳥
• 魚
• 爬蟲類
• 兩棲類

第5章：全球野生動物健康市場：依產品分類

• 市場分析、洞察與預測
• 製藥
• 設備/耗材

第6章：全球野生動物保健市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 注射藥物
• 其他

第7章：全球野生動物健康市場：依最終用戶分類

• 市場分析、洞察與預測
• 動物園
• 野生動物保護區
• 野生動物救援與康復中心
• 其他

第8章：全球野生動物健康市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Merck & Co. Inc.（MSD Animal Health）
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • IDEXX Laboratories Inc
  • Orion Corporation
  • Virbac SA
  • Ceva Sante Animale
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Huvepharma EOOD
  • Vetoquinol SA
  • Indian Immunologicals Limited

The global wildlife health market size is expected to reach USD 8.02 Billion in 2034 from USD 3.18 Billion in 2025, growing at a CAGR of 10.82 during 2026-2034.This market is expanding steadily due to increasing awareness regarding biodiversity conservation, zoonotic disease prevention, and ecosystem sustainability. Governments, conservation agencies, and research organizations are investing in wildlife disease surveillance, veterinary care, and habitat protection to safeguard animal populations. Growing recognition of the connection between wildlife health, environmental stability, and public health is further supporting industry growth.

Advancements in wildlife diagnostics, disease monitoring technologies, molecular testing, and remote tracking systems are improving the detection and management of infectious diseases among wild animal populations. Conservation programs are increasingly utilizing digital health monitoring tools and advanced veterinary treatments to improve rehabilitation outcomes. Collaborative research initiatives are also strengthening disease prevention strategies across global ecosystems.

Future prospects remain promising as investments increase in wildlife conservation, environmental monitoring, and advanced veterinary research. Artificial intelligence, genomic analysis, and remote sensing technologies are expected to improve disease surveillance and ecological management. Continued global focus on biodiversity protection and One Health initiatives will generate substantial opportunities for long-term industry development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Animal Type

• Mammals
• Birds
• Fish
• Reptiles
• Amphibians

By Product

• Medicine
• Equipment and Consumables

By Route of Administration

• Oral
• Injectable
• Other Routes of Administration

By End User

• Zoos
• Wildlife Sanctuaries
• Wildlife Rescue and Rehab Centers
• Other End Users

COMPANIES PROFILED

• Merck & Co. Inc. (MSD Animal Health), Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Orion Corporation, Virbac SA, Ceva Sante Animale, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Huvepharma EOOD, Vetoquinol SA, Indian Immunologicals Limited

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL WILDLIFE HEALTH MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal Type
• 4.2. Mammals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Birds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fish Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Reptiles Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Amphibians Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL WILDLIFE HEALTH MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Equipment and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL WILDLIFE HEALTH MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Routes of Administration Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL WILDLIFE HEALTH MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Zoos Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Wildlife Sanctuaries Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Wildlife Rescue and Rehab Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL WILDLIFE HEALTH MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Animal Type
  • 8.2.2 By Product
  • 8.2.3 By Route Of Administration
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Animal Type
  • 8.3.2 By Product
  • 8.3.3 By Route Of Administration
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Animal Type
  • 8.4.2 By Product
  • 8.4.3 By Route Of Administration
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Animal Type
  • 8.5.2 By Product
  • 8.5.3 By Route Of Administration
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Animal Type
  • 8.6.2 By Product
  • 8.6.3 By Route Of Administration
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL WILDLIFE HEALTH INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Merck & Co. Inc. (MSD Animal Health)
  • 10.2.2 Boehringer Ingelheim International GmbH
  • 10.2.3 Elanco Animal Health Incorporated
  • 10.2.4 IDEXX Laboratories Inc
  • 10.2.5 Orion Corporation
  • 10.2.6 Virbac SA
  • 10.2.7 Ceva Sante Animale
  • 10.2.8 Phibro Animal Health Corporation
  • 10.2.9 Dechra Pharmaceuticals PLC
  • 10.2.10 Huvepharma EOOD
  • 10.2.11 Vetoquinol SA
  • 10.2.12 Indian Immunologicals Limited